Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Personalized Medicine
|
January 20, 2021
Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
Niall M Byrne, Prajakta Tambe, Jonathan A Coulter
JBMR Plus
|
March 29, 2019
Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities
Niall M Byrne, Matthew A Summers, Michelle M McDonald
Cancers
|
December 15, 2019
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Jie Feng, Niall M Byrne, Wafa Al Jamal, et al.
Chemical Communications (Cambridge, England)
|
July 14, 2012
Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy
Nikolitsa Nomikou, Colin Fowley, Niall M Byrne, et al.
Drug Delivery and Translational Research
|
July 15, 2023
Urethane dimethacrylate-based photopolymerizable resins for stereolithography 3D printing: A physicochemical characterisation and biocompatibility evaluation
Giulia Pitzanti, Valentyn Mohylyuk, Francesca Corduas, et al.
Journal of Cellular Physiology
|
July 21, 2015
Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo
Heather Nesbitt, Gillian Browne, Katie M O'Donovan, et al.
Cell Communication and Signaling : CCS
|
April 2, 2025
Atovaquone-induced activation of the PERK/eIF2α signaling axis mitigates metabolic radiosensitisation
Jie Feng, Varun Pathak, Niall M Byrne, et al.
International Journal of Cancer
|
August 24, 2012
Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response
Louise Ming, Niall M Byrne, Sarah Nicole Camac, et al.
ACS Biomaterials Science & Engineering
|
January 28, 2026
Metabolic Radiosensitization by Targeting Lactate Metabolism with Microfluidic Liposomal Nanocarriers
Meabh Doherty, Jie Feng, Tongchuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2016
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
Heather Nesbitt, Niall M Byrne, S Nicole Williams, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Personalized Medicine
|
January 20, 2021
Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives
Niall M Byrne, Prajakta Tambe, Jonathan A Coulter
JBMR Plus
|
March 29, 2019
Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities
Niall M Byrne, Matthew A Summers, Michelle M McDonald
Cancers
|
December 15, 2019
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Jie Feng, Niall M Byrne, Wafa Al Jamal, et al.
Chemical Communications (Cambridge, England)
|
July 14, 2012
Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy
Nikolitsa Nomikou, Colin Fowley, Niall M Byrne, et al.
Drug Delivery and Translational Research
|
July 15, 2023
Urethane dimethacrylate-based photopolymerizable resins for stereolithography 3D printing: A physicochemical characterisation and biocompatibility evaluation
Giulia Pitzanti, Valentyn Mohylyuk, Francesca Corduas, et al.
Journal of Cellular Physiology
|
July 21, 2015
Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo
Heather Nesbitt, Gillian Browne, Katie M O'Donovan, et al.
Cell Communication and Signaling : CCS
|
April 2, 2025
Atovaquone-induced activation of the PERK/eIF2α signaling axis mitigates metabolic radiosensitisation
Jie Feng, Varun Pathak, Niall M Byrne, et al.
International Journal of Cancer
|
August 24, 2012
Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response
Louise Ming, Niall M Byrne, Sarah Nicole Camac, et al.
ACS Biomaterials Science & Engineering
|
January 28, 2026
Metabolic Radiosensitization by Targeting Lactate Metabolism with Microfluidic Liposomal Nanocarriers
Meabh Doherty, Jie Feng, Tongchuan Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2016
Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
Heather Nesbitt, Niall M Byrne, S Nicole Williams, et al.
Page
of 2